Bhaskar Chaudhuri - 20 Apr 2021 Form 4/A - Amendment Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role: Director
Signature: /s/ Scott Burrows, as Attorney-in-Fact for Bhaskar Chaudhuri
Issuer symbol: ARQT
Transactions as of: 20 Apr 2021
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 12 May 2021, 18:19:32 UTC
Date Of Original Report: 22 Apr 2021
Next filing: 03 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ARQT	Common Stock						871,391	20 Apr 2021	Direct	F1
holding	ARQT	Common Stock						49,981	20 Apr 2021	By Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale transactions originally reported on lines 1 and 2 of the Form 4 filed by the Reporting Person on 4/22/2021 did not occur. This Form 4/A corrects the aforementioned error by removing the transactions and adjusting the Reporting Person's direct ownership accordingly.
F2	The securities are held of record by The Chaudhuri Family Trust, of which the Reporting Person is trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.

Content

The sale transactions originally reported on lines 1 and 2 of the Form 4 filed by the Reporting Person on 4/22/2021 did not occur. This Form 4/A corrects the aforementioned error by removing the transactions and adjusting the Reporting Person's direct ownership accordingly.

The securities are held of record by The Chaudhuri Family Trust, of which the Reporting Person is trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.